To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Chemokine CC motif ligand 5 (RANTES; CCL5); defensin α 1 (DEFA1; HNP-1)

Cardiovascular disease

INDICATION: Inflammation; myocardial infarction (MI)

Cell and mouse studies identified a peptide inhibitor of DEFA1-RANTES

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE